IL6 and chronic kidney disease: Individuals with CKD present elevated levels of key inflammatory and oxidative markers, including interleukin-6 (IL-6), tumor necrosis factor-α (TNF-α), and C-reactive protein (CRP), and malondialdehyde (MDA), which may increase with the glomerular filtration decline and increased cardiovascular disease risk [4].